AU2003260515A8 - Derivatives of 4-4'-bipyridyl-2-2'-bisoxazoles and 4-4'-bipyridyl-2-2'-bistiazoles as antineoplasic agents - Google Patents
Derivatives of 4-4'-bipyridyl-2-2'-bisoxazoles and 4-4'-bipyridyl-2-2'-bistiazoles as antineoplasic agentsInfo
- Publication number
- AU2003260515A8 AU2003260515A8 AU2003260515A AU2003260515A AU2003260515A8 AU 2003260515 A8 AU2003260515 A8 AU 2003260515A8 AU 2003260515 A AU2003260515 A AU 2003260515A AU 2003260515 A AU2003260515 A AU 2003260515A AU 2003260515 A8 AU2003260515 A8 AU 2003260515A8
- Authority
- AU
- Australia
- Prior art keywords
- bipyridyl
- bistiazoles
- bisoxazoles
- derivatives
- antineoplasic agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200201938A ES2200706B1 (en) | 2002-08-16 | 2002-08-16 | DERIVATIVES OF 4-4'-BIPIRIDIL-2-2'-BISOXAZOLES AND 4-4'-BIPIRIDIL-2-2'-BISTIAZOLES AS ANTINEOPLASICAL AGENTS. |
ESP200201938 | 2002-08-16 | ||
PCT/ES2003/000424 WO2004016622A1 (en) | 2002-08-16 | 2003-08-14 | Derivatives of 4-4'-bipyridyl-2-2'-bisoxazoles and 4-4'-bipyridyl-2-2'-bistiazoles as antineoplasic agents |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003260515A1 AU2003260515A1 (en) | 2004-03-03 |
AU2003260515A8 true AU2003260515A8 (en) | 2004-03-03 |
Family
ID=31725576
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003260515A Abandoned AU2003260515A1 (en) | 2002-08-16 | 2003-08-14 | Derivatives of 4-4'-bipyridyl-2-2'-bisoxazoles and 4-4'-bipyridyl-2-2'-bistiazoles as antineoplasic agents |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003260515A1 (en) |
ES (1) | ES2200706B1 (en) |
WO (1) | WO2004016622A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2344780B1 (en) * | 2009-03-03 | 2011-07-22 | Universidad De Barcelona | USEFUL BISTIAZOLIC COMPOUNDS FOR THE TREATMENT OF CANCER. |
WO2012028757A1 (en) | 2010-09-02 | 2012-03-08 | Universitat De Barcelona | Fluorinated thiazoles for use in treating cancer |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3148194A (en) * | 1961-07-03 | 1964-09-08 | Arapahoe Chemicals Inc | Certain 1, 4-bis[2(4-substituted, 5-phenyloxazolyl)] benzenes |
FR2066252A5 (en) * | 1970-10-20 | 1971-08-06 | Sumitomo Chemical Co | Oxazolyl optical brighteners for textiles and plastics |
DD260698A1 (en) * | 1986-11-27 | 1988-10-05 | Tech Hochschule C Schorlemmer | METHOD FOR THE PRODUCTION OF BIS-OXAZOLIUM SALTS |
JP2000318313A (en) * | 1999-05-07 | 2000-11-21 | Mitsui Chemicals Inc | Optical recording medium |
-
2002
- 2002-08-16 ES ES200201938A patent/ES2200706B1/en not_active Expired - Fee Related
-
2003
- 2003-08-14 AU AU2003260515A patent/AU2003260515A1/en not_active Abandoned
- 2003-08-14 WO PCT/ES2003/000424 patent/WO2004016622A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2003260515A1 (en) | 2004-03-03 |
ES2200706A1 (en) | 2004-03-01 |
WO2004016622A1 (en) | 2004-02-26 |
ES2200706B1 (en) | 2005-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1226399A1 (en) | Pyridazine derivatives and their use as therapeutic agents | |
EP1465615A4 (en) | Tricyclic-bis-enone derivatives and methods of use thereof | |
HK1079789A1 (en) | Vasculostatic agents and methods of use thereof | |
PL376532A1 (en) | Substituted benzylamine derivatives and methods of use | |
AU2003259735A8 (en) | Small-mer compositions and methods of use | |
HK1068874A1 (en) | Heterocyclic compounds and methods of use | |
AU2003217870A8 (en) | Pini-modulating compounds and methods of use thereof | |
AU2003213673A8 (en) | Pin1-modulating compounds and methods of use thereof | |
EP1227821A4 (en) | Therapeutic compositions and methods of use thereof | |
AU2003223579A8 (en) | Combinations of cox-2 inhibitors and other agents for the treatment of parkinson's disease | |
ZA200410409B (en) | Use of thio-oxindole derivatives in treatment of hormonerelated conditions | |
GB0004167D0 (en) | 1-piperidinyl-propan-2-ol derivatives and their use as therapeutic agents | |
IL158181A0 (en) | N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity | |
EP1377295A4 (en) | Carboxamide derivatives as therapeutic agents | |
SI1337521T1 (en) | Salts of an isothiazole-4-carboxamide and their use as anti-hyperproliferation agents | |
AU2003299441A8 (en) | Nf-hev compositions and methods of use | |
PL371281A1 (en) | Methods and compositions for the treatment of eye diseases | |
AU2003239868A8 (en) | Sunscreen compositions and methods of use thereof | |
PL375564A1 (en) | Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma | |
AU2003297612A8 (en) | 2-substituted-3-propenamide derivatives and methods of using the same | |
EP1455780A4 (en) | Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma | |
EP1545287A4 (en) | Vasoregulating compounds and methods of their use | |
IL165612A0 (en) | Novel arylimidazole derivatives preparation and therapeutic uses thereof | |
AU2003244455A1 (en) | Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases | |
AU2003260515A8 (en) | Derivatives of 4-4'-bipyridyl-2-2'-bisoxazoles and 4-4'-bipyridyl-2-2'-bistiazoles as antineoplasic agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |